Our next webinar, scheduled for Wednesday, September 11, from noon to 1 PM EST, addresses a topic that is much discussed in our Facebook communities: cannabidiol (CBD) and medical marijuana. With the spread of legalized medical marijuana and the passage of the 2018 Farm Bill that made CBD legal in all 50 states, it’s a bit of the Wild West out there for individuals seeking relief from chronic pain, inflammation, anxiety, and a host of other symptoms that have been reported to be alleviated by CBD. What does the research say? How can consumers know what’s safe and effective? Our presenter, Jen Bernstein, is deeply knowledgeable about these issues and is an advocate for setting industry standards. She is CEO of What Heals All and co-founder and president of the Women’s Cannabis Club, as well as former managing editor of High Times magazine. Join us to learn and have your questions answered.
Please note: Your confirmation email will contain a unique link to access this webinar. Please save this confirmation email to access the webinar on September 11.
According to https://pubmed.ncbi.nlm.nih.gov/?term=cbd+oil, third-party lab testing is a crucial component of the regulatory environment of cannabis and the cannabinoids derived from it. It is a process when a private laboratory or one not associated with a manufacturer or distributor performs scientific tests to analyze the CBD product. With this process, it gives results to customers that are honest and detailed information on the products they buy. The process includes mold, pesticides, and solvents testing, cannabinoid profiling and verification that focuses on the safety of the product for public consumption
Make sure it’s third-party lab tested like CBD products available at https://biomdplus.com/cbd-oil-for-anxiety/